Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending February 26, 2008. The report serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons, specifically regarding a correction of an administrative error within the GlaxoSmithKline Share Value Plan.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure of a specific share transaction rather than a financial performance report.
Material Changes
The filing details a transaction involving Dr. M. Slaoui's Connected Person. On February 5, 2008, 213 Ordinary shares were acquired at a price of GBP 12.84 each. This transaction was executed to correct an administrative error that occurred following the release of Plan shares on December 3, 2007.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. The document is strictly a notification under Disclosure and Transparency Rule 3.1.4R(1)(a).
Key Facts for Investor Verification
- Transaction Date: February 5, 2008.
- Shares Acquired: 213 Ordinary shares.
- Price per Share: GBP 12.84.
- Reason for Transaction: Correction of an administrative error related to the Share Value Plan.
- Related Party: Connected Person of Dr. M. Slaoui.